Cryoport

Company Overview
Company Details
Case Studies
Stemedica’s Clinical Trial Using Cryoport Logistics
Aug 16th, 2016
Companies expand agreement as biotech firm Stemedic uses Cryoport shippers and monitoring systems for a new Phase II clinical trial to assess a stem cell therapy for the treatment of Alzheimer's disease.
Stemedica’s Clinical Trial Using Cryoport Logistics
Aug 16th, 2016
Cryoport Chosen to Provide Cold Chain Logistics Support to ProteoGenex
Apr 4th, 2016
Company News
Cryoport, World Courier Ink Logistics Deal for Gene Therapies
Jul 17th, 2018
Cryoport, World Courier Ink Logistics Deal for Gene Therapies
Jul 17th, 2018
Cryoport: Cryoport. Certified. Cool.
Aug 15th, 2017
The C3 ™ shipper is designed to provide cold chain logistics in the 2°C – 8°C temperature range for regenerative therapy requirements.
Cryoport: Cryoport. Certified. Cool.
Aug 15th, 2017
Novartis, Cryoport Reach Logistics Agreement
Jul 27th, 2017
More from Cryoport
Cryoport, World Courier Ink Logistics Deal for Gene Therapies
Partnership to support the delivery of cell and gene therapies globally with a full suite of temperature-controlled products.
Jul 17th, 2018
Cryoport, World Courier Ink Logistics Deal for Gene Therapies
Partnership to support the delivery of cell and gene therapies globally with a full suite of temperature-controlled products.
Jul 17th, 2018
Cryoport: Cryoport. Certified. Cool.
The C3 ™ shipper is designed to provide cold chain logistics in the 2°C – 8°C temperature range for regenerative therapy requirements.
Aug 15th, 2017
The C3 ™ shipper is designed to provide cold chain logistics in the 2°C – 8°C temperature range for regenerative therapy requirements.
Cryoport: Cryoport. Certified. Cool.
The C3 ™ shipper is designed to provide cold chain logistics in the 2°C – 8°C temperature range for regenerative therapy requirements.
Aug 15th, 2017
Novartis, Cryoport Reach Logistics Agreement
Three-year agreement provides cryogenic logistics support for launch of potential treatment for relapsed/refractory acute lymphoblastic leukemia.
Jul 27th, 2017
Determining the Impact of Packaging and Logistics on the CAR-T Clinical Pipeline
Sept. 14 presentation addresses the systematic study of the impact of logistics decisions on the integrity of critical biomarkers and active clinical product and data generation.
Sep 12th, 2016
Sept. 14 presentation addresses the systematic study of the impact of logistics decisions on the integrity of critical biomarkers and active clinical product and data generation.
Determining the Impact of Packaging and Logistics on the CAR-T Clinical Pipeline
Sept. 14 presentation addresses the systematic study of the impact of logistics decisions on the integrity of critical biomarkers and active clinical product and data generation.
Sep 12th, 2016
Logistics Study to Evaluate Temperature and Transport Packaging
KCAS and Heat Biologics partner with Cryoport on critical bioanalytical materials and their influence on the data generated and required to support drug development programs.
Aug 30th, 2016
KCAS and Heat Biologics partner with Cryoport on critical bioanalytical materials and their influence on the data generated and required to support drug development programs. Image here for illustrative purposes only.
Logistics Study to Evaluate Temperature and Transport Packaging
KCAS and Heat Biologics partner with Cryoport on critical bioanalytical materials and their influence on the data generated and required to support drug development programs.
Aug 30th, 2016